News

Start of inclusion of additional group of 10 patients in the ongoing US based phase I trial in malignant melanoma
(1 October 2019)

News

Technology

Ultimovacs is developing a universal cancer vaccine applicable across a broad spectrum of cancer types.

Technology

Clinical studies

Lead product tested in three clinical trials, strong results justifies the initiation of a registration trial.

Clinical studies